Literature DB >> 2974919

Increased amount of a 25-kilodalton phosphoprotein after v-mos transfection of CHO cells.

J K Mayo1, K E Sampson, L D Adams, E R Crumm, S L Kelly, I Abraham.   

Abstract

We transfected Chinese hamster ovary (CHO) cells with a cloned v-mos gene (pHT25). The mos family of oncogenes has previously been shown to have serine-threonine kinase activity. This kinase activity may be required for oncogenic transformation, although its exact biological role is unknown. We found that the transfected cells had an altered morphology, a slower doubling time, and an apparent increase in the amount of a 25-kilodalton (kDa) phosphoprotein that appeared to be of low abundance. Transfection of CHO cells with a cloned temperature-sensitive mos gene (ts159) led to isolation of a cell line that showed the presence of the 25-kDa phosphoprotein at the permissive but not at the nonpermissive temperature, suggesting a direct relationship between mos activity and the presence of this phosphoprotein. The characteristics of altered morphology and depressed growth rate were reminiscent of changes seen after the activation of the cyclic AMP-dependent protein kinase (PKA) in CHO cells. However, PKA activation did not stimulate phosphorylation of this 25-kDa protein, nor was there a change in total PKA activity in these cells. We suggest that the increased presence of the 25-kDa phosphoprotein is a consequence of the v-mos transfection and that it may be involved in the change of morphology and growth rate seen in the CHO cells. Phosphorylation of this protein may be a useful marker of mos and have some functional importance in the transformation of cells by the v-mos oncogene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974919      PMCID: PMC365558          DOI: 10.1128/mcb.8.11.4685-4691.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Assay of cyclic AMP-dependent protein kinases.

Authors:  J D Corbin; E M Reimann
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  Long terminal repeat enhancement of v-mos transforming activity: identification of essential regions.

Authors:  T G Wood; M L McGeady; D G Blair; G F Vande Woude
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.

Authors:  J Papkoff; E A Nigg; T Hunter
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

8.  Nucleotide sequence of avian retroviral oncogene v-mil: homologue of murine retroviral oncogene v-raf.

Authors:  P Sutrave; T I Bonner; U R Rapp; H W Jansen; T Patschinsky; K Bister
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

9.  Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related.

Authors:  W Ostertag; M Freshney; K Vehmeyer; C Jasmin; G Rutter
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity.

Authors:  W S Kloetzer; S A Maxwell; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.